Editorial 2: Towards better TB control

Context

A comprehensive approach is required, integrating system-wide and community-level actions with a strong focus on individuals affected by TB.

Introduction

India reports approximately 2.8 million new TB cases each year, accounting for over 25% of the global TB burden. More than half of TB patients in the country seek treatment from private healthcare providers. Currently, TB treatment is available either in public hospitals, where it is free but the environment may not be very welcoming, or in private hospitals, which offer a more comfortable setting but can be expensive.

Public and private care

Government hospitals can offer a standardised clinical algorithm and Challenges in TB Treatment

• Concerns in Public Healthcare:
  • Free treatment is available.
  • Patients worry about the quality of drugs and testing.
  • The healthcare environment may not be welcoming.
  • Strong monitoring and contact tracing are in place.
• Challenges in Private Healthcare:
  • More comfortable and patient-friendly environment.
  • Treatment protocols may not always follow standardized guidelines.
  • Compliance and follow-up monitoring may be weak.
  • Higher costs can make treatment unaffordable for many.

Need for Innovations in TB Care

• To achieve the WHO goal of TB elimination, innovative approaches in diagnosis and treatment are necessary.
• A public-private partnership (PPP) model can address system inefficiencies by:
  • Providing patients with treatment choices.
  • Ensuring better treatment outcomes.
  • Encouraging shared responsibility between public and private health sectors.

A Balanced Healthcare Model

• Hybrid Approach: Combines the strengths of public and private healthcare.
• Clearly Defined Diagnostic Pathways:
  • Evidence-based protocols to minimize variability.
  • Standardized treatment methods across both sectors.
• Ensuring Compliance & Monitoring:
  • Stronger follow-up mechanisms in private care.
  • Improved drug quality and testing in public care.
• This integrated approach ensures patient choice without compromising outcomes, making it a strong step toward TB elimination.

Availability of medicines

• Certain anti-TB medicines for drug-resistant TB are available only in government hospitals to prevent misuse and resistance development.
• To ensure strict adherence to treatment, public health policies require two weeks of hospital admission at the start of treatment for drug-resistant cases.
• This can be challenging for patients who need these novel medicines but are unwilling to be admitted to government hospitals.
• Follow-up care is better in government hospitals, where:
  • Free medicines are provided.
  • Patients have access to social workers for support.
• Proposed Solution: A collaboration between public and private systems, ensuring:
  • Flexible care pathways for patient convenience.
  • Wider access to essential medicines.
  • No compromise on diagnostic and treatment protocols.
• This integrated approach will benefit patients while maintaining treatment standards.

The way forward

• Patient Care & Transition:
  • Establish contact and ensure smooth transition between healthcare providers.
  • Define logistics of cooperation to prevent patients from being lost in the system.
  • Address accountability issues in treatment and follow-up.
• Regulating TB Treatment & Diagnosis:
  • Unregistered practitioners treating TB pose a risk.
  • Diagnosis should follow standard definitions and testing methods.
  • Regulated drug supply is needed to prevent misuse and ensure adherence to treatment protocols.
  • Strong follow-up mechanisms must be in place for better patient outcomes.

Future Directions in TB Treatment

• Regulation of Laboratories:
  • Laboratories must follow strict quality control standards.
  • Clinical details should accompany TB test specimens to improve accuracy.
• Centralized Monitoring of TB Cases:
  • All TB test results should be reported to a centralized cell for coordination.
  • Pharmacies selling TB medicines should be monitored to prevent misuse.
  • An expert committee should provide feedback to treating doctors to ensure best practices.

Conclusion

There is no single path to success. Rethinking partnerships, challenging conventional norms, and reframing problems can provide more effective strategies and pathways for achieving success in TB control, fostering innovation and improved outcomes in the fight against the disease.